Drug Shortage Report for APO-NAPROXEN EC TABLETS

Last updated on 2021-01-19 History
Report ID 130410
Drug Identification Number 02246699
Brand name APO-NAPROXEN EC TABLETS
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 250MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-15
Estimated end date 2021-01-15
Actual end date 2021-01-15
Shortage status Resolved
Updated date 2021-01-19
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-19 French Compare
v5 2021-01-19 English Compare
v4 2021-01-04 French Compare
v3 2021-01-04 English Compare
v2 2020-12-18 French Compare
v1 2020-12-18 English Compare